© 2014

Carbohydrates as Drugs

  • Peter H. Seeberger
  • Christoph Rademacher


  • Overview chapters introduce the newcomer to the topic covered

  • Series covers hot topics of frontier research summarized by reputed scientists in the field

  • Volumes are useful and of relevance for a long period of time


Part of the Topics in Medicinal Chemistry book series (TMC, volume 12)

Table of contents

  1. Front Matter
    Pages i-vii
  2. Markus Leibeling, Daniel B. Werz
    Pages 1-21
  3. Alison Mackinnon, Wei-Sheng Chen, Hakon Leffler, Noorjahan Panjwani, Hans Schambye, Tariq Sethi et al.
    Pages 95-121
  4. Sébastien G. Gouin, Goedele Roos, Julie Bouckaert
    Pages 123-168
  5. Back Matter
    Pages 235-237

About this book


Medicinal chemistry is both science and art. The science of medicinal chemistry offers mankind one of its best hopes for improving the quality of life. The art of medicinal chemistry continues to challenge its practitioners with the need for both intuition and experience to discover new drugs. Hence sharing the experience of drug research is uniquely beneficial to the field of medicinal chemistry. Drug research requires interdisciplinary team-work at the interface between chemistry, biology and medicine. Therefore, the topic-related series Topics in Medicinal Chemistry covers all relevant aspects of drug research, e.g. pathobiochemistry of diseases, identification and validation of (emerging) drug targets, structural biology, drugability of targets, drug design approaches, chemogenomics, synthetic chemistry including combinatorial methods, bioorganic chemistry, natural compounds, high-throughput screening, pharmacological in vitro and in vivo investigations, drug-receptor interactions on the molecular level, structure-activity relationships, drug absorption, distribution, metabolism, elimination, toxicology and pharmacogenomics. In general, special volumes are edited by well known guest editors.


Anti-Influenza Virus Carbohydrate-Based Drugs Carbohydrate-Based Drugs Carbohydrate-Based Synthetic Chemistry Computational Docking FimH Antagonists Galectin Modulators Glycosyltransferase Inhibitors Imunosugars Structure-Based Design

Editors and affiliations

  • Peter H. Seeberger
    • 1
  • Christoph Rademacher
    • 2
  1. 1.Department of Biomolecular SystemsMax Planck Institute of Colloids and InterfacesPotsdamGermany
  2. 2.Department of Biomolecular SystemsMax Planck Institute of Colloids and InterfacesPotsdamGermany

Bibliographic information

Industry Sectors
Chemical Manufacturing